The male contraceptive regimen of testosterone and levonorgestrel significantly increases lean mass in healthy young men in 4 weeks, but attenuates a decrease in fat mass induced by testosterone alone
- PMID: 12629101
- DOI: 10.1210/jc.2002-020918
The male contraceptive regimen of testosterone and levonorgestrel significantly increases lean mass in healthy young men in 4 weeks, but attenuates a decrease in fat mass induced by testosterone alone
Abstract
In hypogonadal men, testosterone (T) in replacement dosages is known to increase fat-free mass (lean mass) and decrease fat mass. In young eugonadal men, similar dosages of T increase lean mass, but much higher dosages of T are required to decrease total body fat mass. Current T-based male hormonal contraceptive regimens include a second agent, such as a progestin, to maximize inhibition of pituitary gonadotropins and improve efficacy. To study the effect of such combinations on body composition, we randomized healthy, young, eugonadal men into four combinations of exogenous T and the progestin, levonorgestrel (LNG): 1) 100 mg T enanthate, im, weekly plus 125 micro g LNG, orally, daily (T+LNG); 2) T plus placebo LNG (T alone); 3) placebo T plus LNG (LNG alone); and 4) placebo T plus placebo LNG (placebo). We then analyzed body composition by dual energy x-ray absorptiometry after 4 and 8 wk of treatment. T+LNG significantly increased total lean mass after 4 and 8 wk of treatment (3.5 +/- 0.9% and 4.2 +/- 1.2%, respectively; P < 0.05) and truncal lean mass after 4 and 8 wk of treatment (4.7 +/- 0.9% and 5.0 +/- 0.9%, respectively; P < 0.05) compared with baseline and placebo. T alone also increased total and truncal lean mass significantly compared with placebo after 4 wk of treatment, but not compared with baseline (3.3 +/- 1.4% and 3.2 +/- 2.3%, respectively; P < 0.05 vs. placebo), suggesting an additive effect of T and LNG to increase lean mass. Fat mass significantly decreased in the abdomen in men administered T alone compared with LNG alone (-4.9 +/- 2.8%; P < 0.05). Fat mass significantly increased in the abdomen with LNG alone (4.1 +/- 1.0%; P < 0.05) compared with baseline and was unchanged with the combination of T+LNG, suggesting that LNG attenuates the decrease in fat mass seen with T alone. There was no change in weight or body mass index in any group during the study. This study shows that in young eugonadal men 1) T alone rapidly increases lean mass and decreases fat mass in 4-8 wk; 2) T+LNG rapidly increases lean mass, but has no effect on fat mass; and 3) LNG alone increases fat mass. The favorable profile on body composition by T is, therefore, partially attenuated by the progestin, LNG. These findings suggest that androgen-based male hormonal contraceptives might have favorable effects on body composition. The impact of these changes on cardiovascular risk in normal men needs further study.
Similar articles
-
Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach.J Clin Endocrinol Metab. 1996 Feb;81(2):757-62. doi: 10.1210/jcem.81.2.8636300. J Clin Endocrinol Metab. 1996. PMID: 8636300 Clinical Trial.
-
Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone.J Clin Endocrinol Metab. 2002 Aug;87(8):3562-72. doi: 10.1210/jcem.87.8.8710. J Clin Endocrinol Metab. 2002. PMID: 12161475 Clinical Trial.
-
A lower dosage levonorgestrel and testosterone combination effectively suppresses spermatogenesis and circulating gonadotropin levels with fewer metabolic effects than higher dosage combinations.J Androl. 1999 May-Jun;20(3):407-14. J Androl. 1999. PMID: 10386821 Clinical Trial.
-
Testosterone, body composition and aging.J Endocrinol Invest. 1999;22(5 Suppl):110-6. J Endocrinol Invest. 1999. PMID: 10442580 Review.
-
Androgen effects on body composition.Growth Horm IGF Res. 2003 Aug;13 Suppl A:S63-71. doi: 10.1016/s1096-6374(03)00058-3. Growth Horm IGF Res. 2003. PMID: 12914730 Review.
Cited by
-
Testosterone replacement therapy and cardiovascular risk.Nat Rev Cardiol. 2019 Sep;16(9):555-574. doi: 10.1038/s41569-019-0211-4. Nat Rev Cardiol. 2019. PMID: 31123340 Review.
-
Advances in male contraception.Endocr Rev. 2008 Jun;29(4):465-93. doi: 10.1210/er.2007-0041. Epub 2008 Apr 24. Endocr Rev. 2008. PMID: 18436704 Free PMC article. Review.
-
Male hormonal contraception: looking back and moving forward.Andrology. 2016 Jan;4(1):4-12. doi: 10.1111/andr.12110. Epub 2015 Oct 9. Andrology. 2016. PMID: 26453296 Free PMC article. Review.
-
The future of male contraception: a fertile ground.Transl Androl Urol. 2018 May;7(Suppl 2):S220-S235. doi: 10.21037/tau.2018.03.23. Transl Androl Urol. 2018. PMID: 29928620 Free PMC article. Review.
-
Male contraception.Best Pract Res Clin Obstet Gynaecol. 2014 Aug;28(6):845-57. doi: 10.1016/j.bpobgyn.2014.05.008. Epub 2014 Jun 5. Best Pract Res Clin Obstet Gynaecol. 2014. PMID: 24947599 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources